
The world's first minimally invasive, reversible ostomy device.
A 20-minute percutaneous intervention replacing open surgery.
Patients avoid surgery due to poor outcomes and quality of life
Up to $60,000 total cost
30% severe complication rate
Up to 55,000 deaths per year
* US only

The world's first minimally invasive ostomy. A percutaneous device that accesses the bowel through a single needle puncture and reverses when the crisis passes.

Local anesthesia needle access. No operating room. No general anesthesia. A procedure that takes 20 minutes.
Office-based stoma closure. The stent is removed when no longer indicated, restoring continuity without a second surgery.
From needle puncture to active stoma in two steps and 20 minutes.

The patent-pending Pexy device is deployed through a single needle puncture under local anesthesia, anchoring the stoma to the abdominal wall without sutures or open incision.

A decompressive stent is introduced through the fixation point, creating a controlled ostomy that relieves bowel obstruction in minutes — and is removable when the obstruction resolves.
The US-only serviceable addressable market spans three distinct revenue streams across decompression, protection, and recurring disposables.
135,000 patients/year requiring decompression for bowel obstruction
145,000 patients/year requiring protective ostomy during surgical recovery
Recurring revenue from per-procedure device kits and stent replacements

Expert in minimally invasive medical devices.

Surgeon and radiologist with deep clinical expertise.

Physician with extensive startup experience.
Pioneer of minimally invasive surgery. Former SAGES President. 350+ publications.
Pioneer of minimally invasive techniques. Inventor. 100+ publications.
For investor conversations, press inquiries, or partnership discussions, reach out directly to our founding team.